The Journal of family practice
-
After participating in this activity on chronic obstructive pulmonary disease (COPD), family physicians will be better able to: Identify symptomatic patients at increased risk of COPD to prompt early diagnostic evaluation. Individualize evidence-based therapy with the goal of reducing COPD exacerbations and improving patient outcomes. Identify the role of fixed triple-combination inhalers as part of individualized therapy.
-
At the end of the activity, participants will be able to: Identify the risks of kidney disease and their consequences in patients with T2DM. Initiate evidence-based therapy to slow the progression of kidney disease in patients with T2DM and CKD. Become familiar with the mineralocorticoid receptor antagonist and endothelin receptor antagonist under latephase investigation.
-
► Limited movement in both arms ► Diffuse pain in elbows, forearms, and upper arms ► Pronated hands.